Additional file 6 of Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

Additional file 6: Table S6A. Factors associated with HRQoL (EORTC QLQ-C30 global health/QoL scale score) from multiple linear regression analysis for patients with HR+/HER2− advanced breast cancer currently receiving initial endocrine-based therapy for advanced disease who provided PRO data in EU5 (n = 252 with at least one data point). Table S6B. Sensitivity analysis: Factors associated with EORTC QLQ-C30 global health/ QoL scale score from the 3-level linear mixed-effects model with country and physician as random effects.